Back to hormonal replacement therapy
- PMID: 40185465
- DOI: 10.1016/j.jbspin.2025.105898
Back to hormonal replacement therapy
Keywords: Breast cancer; Cardiovascular risk; Menopause; Menopause hormone therapy; Osteoporosis; Primary prevention.
Conflict of interest statement
Disclosure of interest FT: lecture or expert fees: Astella, Bayer, Besins Healthcare France, Exeltis, Gédéon Richter France, Idorsia, Théramex. AG: lecture fees: Bayer, Gédéon Richter France.
Publication types
LinkOut - more resources
Full Text Sources
